These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25672588)

  • 1. APE1/Ref-1 as a Serological Biomarker for the Detection of Bladder Cancer.
    Shin JH; Choi S; Lee YR; Park MS; Na YG; Irani K; Lee SD; Park JB; Kim JM; Lim JS; Jeon BH
    Cancer Res Treat; 2015 Oct; 47(4):823-33. PubMed ID: 25672588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary APE1/Ref-1: A Potential Bladder Cancer Biomarker.
    Choi S; Shin JH; Lee YR; Joo HK; Song KH; Na YG; Chang SJ; Lim JS; Jeon BH
    Dis Markers; 2016; 2016():7276502. PubMed ID: 27057081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 Could Serve as a Potential Serological Biomarker for the Diagnosis and Prognosis of Oral Squamous Cell Carcinoma.
    Xie J; Li Y; Kong J; Li C
    J Oral Maxillofac Surg; 2019 Apr; 77(4):859-866. PubMed ID: 30611690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor Activity and Mechanistic Characterization of APE1/Ref-1 Inhibitors in Bladder Cancer.
    Fishel ML; Xia H; McGeown J; McIlwain DW; Elbanna M; Craft AA; Kaimakliotis HZ; Sandusky GE; Zhang C; Pili R; Kelley MR; Jerde TJ
    Mol Cancer Ther; 2019 Nov; 18(11):1947-1960. PubMed ID: 31413178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of apurinic/apyrimidinic endonuclease 1/redox factor-1 on treatment response and survival in oral squamous cell carcinoma.
    Hsia KT; Liu CJ; Mar K; Lin LH; Lin CS; Cheng MF; Lee HS; Chiu SY
    Head Neck; 2016 Apr; 38(4):550-9. PubMed ID: 25482590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.
    Zhang Y; Wang J; Xiang D; Wang D; Xin X
    Int J Oncol; 2009 Nov; 35(5):1069-79. PubMed ID: 19787261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 enhances the sensitivity of human pancreatic cancer cells to radiotherapy in vitro.
    Chen S; Xiong G; Wu S; Mo J
    Cancer Biother Radiopharm; 2013 Mar; 28(2):169-76. PubMed ID: 23268706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical value of serum Ape1/Ref-1 combined with TGF-β1 monitoring in predicting the occurrence of radiation pneumonitis (RP) in non-small cell lung cancer patients.
    Zhang Y; You H; Duan J; Gao Y
    Ann Palliat Med; 2021 Mar; 10(3):3328-3335. PubMed ID: 33849117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevation of Serum APE1/Ref-1 in Experimental Murine Myocarditis.
    Jin SA; Lim BK; Seo HJ; Kim SK; Ahn KT; Jeon BH; Jeong JO
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29292734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer.
    Kelley MR; Cheng L; Foster R; Tritt R; Jiang J; Broshears J; Koch M
    Clin Cancer Res; 2001 Apr; 7(4):824-30. PubMed ID: 11309329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered Secretory Activity of APE1/Ref-1 D148E Variants Identified in Human Patients With Bladder Cancer.
    Lee YR; Lim JS; Shin JH; Choi S; Joo HK; Jeon BH
    Int Neurourol J; 2016 May; 20(Suppl 1):S30-37. PubMed ID: 27230458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of plasma APE1/Ref-1 in lipopolysaccharide-induced endotoxemic rats: implication of serological biomarker for an endotoxemia.
    Park MS; Lee YR; Choi S; Joo HK; Cho EJ; Kim CS; Park JB; Jo EK; Jeon BH
    Biochem Biophys Res Commun; 2013 Jun; 435(4):621-6. PubMed ID: 23685156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APE1/Ref-1 enhances DNA binding activity of mutant p53 in a redox-dependent manner.
    Cun Y; Dai N; Li M; Xiong C; Zhang Q; Sui J; Qian C; Wang D
    Oncol Rep; 2014 Feb; 31(2):901-9. PubMed ID: 24297337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum APE1 as a predictive marker for platinum-based chemotherapy of non-small cell lung cancer patients.
    Zhang S; He L; Dai N; Guan W; Shan J; Yang X; Zhong Z; Qing Y; Jin F; Chen C; Yang Y; Wang H; Baugh L; Tell G; Wilson DM; Li M; Wang D
    Oncotarget; 2016 Nov; 7(47):77482-77494. PubMed ID: 27813497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlations between Ape1/Ref-1, ICAM-1 and IL-17A Levels in Serum and Radiation Pneumonitis for Local Advanced Non-small Cell Lung Cancer Patients].
    Guo L; Ding G; Xu W; Ge H; Jiang Y; Lu Y
    Zhongguo Fei Ai Za Zhi; 2018 May; 21(5):383-388. PubMed ID: 29764588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target.
    Fishel ML; Kelley MR
    Mol Aspects Med; 2007; 28(3-4):375-95. PubMed ID: 17560642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apurinic apyrimidinic endonuclease/redox effector factor 1 immunoreactivity and grading in hepatocellular carcinoma risk of relapse after liver transplantation.
    Avellini C; Orsaria M; Baccarani U; Adani GL; Lorenzin D; Bresadola V; Bresadola F; Beltrami CA
    Transplant Proc; 2010 May; 42(4):1204-8. PubMed ID: 20534262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of a promoter polymorphism in APE1/Ref-1 that contributes to reduced lung cancer susceptibility.
    Lu J; Zhang S; Chen D; Wang H; Wu W; Wang X; Lei Y; Wang J; Qian J; Fan W; Hu Z; Jin L; Shen H; Huang W; Wei Q; Lu D
    FASEB J; 2009 Oct; 23(10):3459-69. PubMed ID: 19541747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrogen peroxide activates APE1/Ref-1 via NF-κB and Parkin: a role in liver cancer resistance to oxidative stress.
    Siswanto FM; Okukawa K; Tamura A; Oguro A; Imaoka S
    Free Radic Res; 2023 Dec; 57(3):223-238. PubMed ID: 37364176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylases inhibitor trichostatin A modulates the extracellular release of APE1/Ref-1.
    Choi S; Lee YR; Park MS; Joo HK; Cho EJ; Kim HS; Kim CS; Park JB; Irani K; Jeon BH
    Biochem Biophys Res Commun; 2013 Jun; 435(3):403-7. PubMed ID: 23665318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.